These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of active and passive human vaccines to treat methamphetamine addiction. Gentry WB; Rüedi-Bettschen D; Owens SM Hum Vaccin; 2009 Apr; 5(4):206-13. PubMed ID: 19276653 [TBL] [Abstract][Full Text] [Related]
3. Animal Models and the Development of Vaccines to Treat Substance Use Disorders. Ohia-Nwoko O; Kosten TA; Haile CN Int Rev Neurobiol; 2016; 126():263-91. PubMed ID: 27055616 [TBL] [Abstract][Full Text] [Related]
7. Immune to the high. Marris E Nat Med; 2008 Apr; 14(4):358-61. PubMed ID: 18391928 [No Abstract] [Full Text] [Related]
8. Methamphetamine use among treatment-seeking adolescents in Southern California: participant characteristics and treatment response. Rawson RA; Gonzales R; Obert JL; McCann MJ; Brethen P J Subst Abuse Treat; 2005 Sep; 29(2):67-74. PubMed ID: 16135335 [TBL] [Abstract][Full Text] [Related]
9. Methods in systems biology of experimental methamphetamine drug abuse. Kobeissy FH; Sadasivan S; Buchanan M; Zhang Z; Gold MS; Wang KK Methods Mol Biol; 2010; 662():303-16. PubMed ID: 20824478 [TBL] [Abstract][Full Text] [Related]
10. Development of vaccines to help treat drug dependence. Bunce CJ; Loudon PT; Akers C; Dobson J; Wood DM Curr Opin Mol Ther; 2003 Feb; 5(1):58-63. PubMed ID: 12669472 [TBL] [Abstract][Full Text] [Related]
11. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research. Clemens KJ; McGregor IS; Hunt GE; Cornish JL Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831 [TBL] [Abstract][Full Text] [Related]
12. No more kicks: there are treatments on the way that promise to destroy the allure of addictive drugs for good. Problem solved? Cohen P New Sci; 2000 Jun; 166(2242):22-6. PubMed ID: 11995723 [No Abstract] [Full Text] [Related]
13. Immunotherapy for the treatment of drug abuse. Kosten T; Owens SM Pharmacol Ther; 2005 Oct; 108(1):76-85. PubMed ID: 16023218 [TBL] [Abstract][Full Text] [Related]
14. Methods in drug abuse neuroproteomics: methamphetamine psychoproteome. Kobeissy FH; Zhang Z; Sadasivan S; Gold MS; Wang KK Methods Mol Biol; 2009; 566():217-28. PubMed ID: 20058175 [TBL] [Abstract][Full Text] [Related]
15. Steps toward change: treating crystal meth dependency. An interview with Yves-Michel Fontaine by Bob Huff. Fontaine YM GMHC Treat Issues; 2005; 19(7-8):10-2. PubMed ID: 16276572 [No Abstract] [Full Text] [Related]
16. Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Cho AK; Melega WP; Kuczenski R; Segal DS Synapse; 2001 Feb; 39(2):161-6. PubMed ID: 11180503 [TBL] [Abstract][Full Text] [Related]
17. Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain. Kaewsuk S; Sae-ung K; Phansuwan-Pujito P; Govitrapong P Neurochem Int; 2009 Nov; 55(6):397-405. PubMed ID: 19409439 [TBL] [Abstract][Full Text] [Related]
18. What's going on with meth? Hagland M Behav Healthc; 2006 Oct; 26(10):20, 22-3. PubMed ID: 17121262 [No Abstract] [Full Text] [Related]
19. Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine. Zhang L; Kitaichi K; Fujimoto Y; Nakayama H; Shimizu E; Iyo M; Hashimoto K Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1381-93. PubMed ID: 16839653 [TBL] [Abstract][Full Text] [Related]
20. The future of vaccines in the management of addictive disorders. Orson FM; Kinsey BM; Singh RA; Wu Y; Gardner T; Kosten TR Curr Psychiatry Rep; 2007 Oct; 9(5):381-7. PubMed ID: 17915077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]